Replies to post #31389 on Biotech Values

[DewDiligence]

IDIX – Sebivo (Telbivudine) for HBV has been submitted to regulatory authorities as follows:

FDA: Dec 2005 (#msg-9102924)
EU: Feb 2006 (#msg-9597987)
China: Mar 2006 (#msg-10366668)

Action dates are Oct 2006 for the FDA and early 2007 for the EU and China.